BDMD (Baird Medical Investment Holdings) Total Stockholders Equity: $34.77 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BDMD Baird Medical Investment Holdings Ltd BDMD
17 GF Score
Price $1.09
! 7 Warning Signs
View Full Analysis

What is Baird Medical Investment Holdings Total Stockholders Equity?

Baird Medical Investment Holdings BDMD +0.43% 17 Total Stockholders Equity is $34.77 Mil as of Jun. 2026. GuruFocus rates BDMD with a GF Score™ of 17/100. The stock has 7 warning signs investors should review.

Baird Medical Investment Holdings's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $34.77 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Baird Medical Investment Holdings's Book Value per Share for the quarter that ended in Jun. 2026 was $1.09. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Baird Medical Investment Holdings's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.41.

Baird Medical Investment Holdings  (NAS:BDMD) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Baird Medical Investment Holdings's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(34.774-0)/31.982
=1.09

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Baird Medical Investment Holdings's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(14.223 + 0) / 34.774
=0.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baird Medical Investment Holdings Total Stockholders Equity Related Terms

Baird Medical Investment Holdings Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Baird Medical Investment Holdings's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baird Medical Investment Holdings Total Stockholders Equity Chart

Baird Medical Investment Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
15.38 25.93 35.75 39.66 31.37

Baird Medical Investment Holdings Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only 39.25 39.66 35.59 31.37 34.77
BDMD
17GF Score
Baird Medical Investment Holdings Ltd BDMD
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $34.77 Mil mean?
Baird Medical Investment Holdings (BDMD) has a Total Stockholders Equity of $34.77 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Baird Medical Investment Holdings and its competitors.
Is Baird Medical Investment Holdings' Total Stockholders Equity too high?
Baird Medical Investment Holdings' current Total Stockholders Equity is $34.77 Mil. Overall, Baird Medical Investment Holdings has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Baird Medical Investment Holdings' Total Stockholders Equity compare to TANAF and NSYS?
Baird Medical Investment Holdings' Total Stockholders Equity of $34.77 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Devices & Instruments company?
A good Total Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Baird Medical Investment Holdings and its competitors. Baird Medical Investment Holdings's current Total Stockholders Equity is $34.77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baird Medical Investment Holdings stock overvalued right now?
Baird Medical Investment Holdings (BDMD) has a current Total Stockholders Equity of $34.77 Mil. The current Total Stockholders Equity is $34.77 Mil. Baird Medical Investment Holdings' overall GF Score™ is 17/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Baird Medical Investment Holdings (BDMD), the current Total Stockholders Equity is $34.77 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Baird Medical Investment Holdings Business Description

Address No.15 Rongtong Street, Room 202, 2nd Floor, Baide Building, Building 11, Yuexiu District, Guangzhou, CHN
Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.
17GF Score

Get the complete analysis for BDMD

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.09
Price